Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
AGEN
AGEN
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
AGEN News
Agenus Advances Immunotherapy with Botensilimab Data Presentation
6d ago
Newsfilter
Agenus Announces First Stakeholder Webcast of 2026 Focused on BOT+BAL Program
Jan 20 2026
Businesswire
Zydus Lifesciences Closes Acquisition of Agenus Assets, Establishes Zylidac Bio LLC
Jan 15 2026
PRnewswire
Zydus Lifesciences Closes Acquisition of Agenus Assets, Establishes Zylidac Bio LLC
Jan 15 2026
Newsfilter
Agenus Receives Approval for Updated AAC Protocol in France Expanding BOT+BAL Access
Jan 12 2026
Newsfilter
Agenus (AGEN) Q1 2025 Earnings Call Transcript
Jan 05 2026
NASDAQ.COM
Oncolytics Biotech Secures FDA Approval for First Pancreatic Cancer Immunotherapy
Dec 12 2025
Newsfilter
Agenus Names Dr. José Iglesias as Chief Medical Affairs Officer to Lead Global Medical Affairs and Early-Access Initiatives, Including France's AAC
Nov 18 2025
Newsfilter
Agenus Stock Jumps 8.67% Following Q3 Results and Clinical Achievements
Nov 10 2025
NASDAQ.COM
Agenus Announces Q3 2025 Results Highlighting Progress in Clinical and Regulatory Areas
Nov 10 2025
Newsfilter
HC Wainwright & Co. Affirms Buy Rating for Agenus, Keeps $23 Price Target Intact
Sep 10 2025
Benzinga
France Approves Reimbursed Compassionate Access (AAC) for Agenus' BOT/BAL in Treating Refractory MSS Metastatic Colorectal Cancer
Sep 09 2025
Newsfilter
FDA Strengthens Survival Criteria as Cancer Drug Market Reaches $866B Milestone
Aug 28 2025
Newsfilter
Update: Agenus Stakeholder Webcast on August 27—Key Transformative IO Developments, BOT/BAL Data Insights, BATTMAN Preview, Progress with Zydus Partnership, and MiNK Highlights
Aug 26 2025
Newsfilter
Anticipated Highlights for Agenus Inc (AGEN) Q2 2025 Earnings Report
Aug 26 2025
Yahoo Finance
Agenus to Present Strategic Developments, Major Achievements, and Future Plans for BOT/BAL in Virtual Stakeholder Briefing on August 27, 2025
Aug 19 2025
Newsfilter
Show More News
